Angiotensin-Converting Enzyme Inhibitors

"Angiotensin-Converting Enzyme Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.

Descriptor ID	D000806
MeSH Number(s)	D27.505.519.389.745.085
Concept/Terms	Angiotensin-Converting Enzyme Inhibitors Angiotensin-Converting Enzyme Inhibitors Angiotensin Converting Enzyme Inhibitors Inhibitors, Kininase II Kininase II Antagonists Kininase II Inhibitors Angiotensin I-Converting Enzyme Inhibitors Angiotensin I Converting Enzyme Inhibitors Antagonists, Angiotensin-Converting Enzyme Antagonists, Angiotensin Converting Enzyme Antagonists, Kininase II Inhibitors, ACE ACE Inhibitors Inhibitors, Angiotensin-Converting Enzyme Enzyme Inhibitors, Angiotensin-Converting Inhibitors, Angiotensin Converting Enzyme Angiotensin-Converting Enzyme Antagonists Angiotensin Converting Enzyme Antagonists Enzyme Antagonists, Angiotensin-Converting

Below are MeSH descriptors whose meaning is more general than "Angiotensin-Converting Enzyme Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Enzyme Inhibitors [D27.505.519.389]
Protease Inhibitors [D27.505.519.389.745]
Angiotensin-Converting Enzyme Inhibitors [D27.505.519.389.745.085]

Below are MeSH descriptors whose meaning is related to "Angiotensin-Converting Enzyme Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Angiotensin-Converting Enzyme Inhibitors".

Angiotensin-Converting Enzyme Inhibitors
Vasopeptidase Inhibitors

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Angiotensin-Converting Enzyme Inhibitors" by people in this website by year, and whether "Angiotensin-Converting Enzyme Inhibitors" was a major or minor topic of these publications.

Bar chart showing 101 publications over 26 distinct years, with a maximum of 9 publications in 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1997	1	0	1
1999	3	2	5
2000	2	1	3
2001	4	3	7
2002	1	1	2
2003	7	2	9
2004	2	1	3
2005	0	5	5
2006	1	4	5
2007	2	5	7
2008	2	4	6
2009	2	2	4
2010	0	5	5
2011	3	1	4
2013	2	0	2
2014	1	3	4
2015	1	0	1
2017	1	3	4
2018	1	0	1
2019	2	1	3
2020	2	0	2
2021	4	3	7
2022	1	6	7
2023	1	0	1
2024	1	0	1

Below are the most recent publications written about "Angiotensin-Converting Enzyme Inhibitors" by people in Profiles.

Fares J, El Fadel O, Zhao J, Li M, Sun J, Roman J, Loizidis G, Summer R. Mortality and Health Outcomes Among Patients With Sarcoidosis Treated With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Chest. 2025 03; 167(3):772-780.

View in: PubMed
Tito S, Manzano JMM, Ogunmola I, Prendergast A, Patel A, Casipit B, Cantu-Martinez O, Jarrett SA, Chiang B, Sarvottam K, Azmaiparashvili Z, Lo KB, Rangaswami J. Cardiovascular Outcomes After Angiotensin Converting Enzyme Inhibitor Induced Angioedema: A Retrospective Cohort Analysis. Am J Cardiol. 2023 10 15; 205:393-395.

View in: PubMed
Derington CG, Bress AP, Moran AE, Weintraub WS, Herrick JS, Cushman WC, Kronish IM, Stults B, Shimbo D, Muntner P, Greene T, Bates JT, Chang TI, Katz LA, Rehman SU, Roumie CL, Tamariz L, King JB. Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial. Hypertension. 2023 03; 80(3):590-597.

View in: PubMed
Weight N, Moledina S, Zoccai GB, Zaman S, Smith T, Siller-Matula J, Dafaalla M, Rashid M, Nolan J, Mamas MA. Impact of pre-existing vascular disease on clinical outcomes. Eur Heart J Qual Care Clin Outcomes. 2022 12 13; 9(1):64-75.

View in: PubMed
Moledina SM, Mannan F, Weight N, Alisiddiq Z, Elbadawi A, Elgendy IY, Fischman DL, Mamas MA. Impact of QRS Duration on Non-ST-Segment Elevation Myocardial Infarction (from a National Registry). Am J Cardiol. 2022 11 15; 183:1-7.

View in: PubMed
Gupta N, Settle L, Brown BR, Armaignac DL, Baram M, Perkins NE, Kaufman M, Melamed RR, Christie AB, Danesh VC, Denson JL, Cheruku SR, Boman K, Bansal V, Kumar VK, Walkey AJ, Domecq JP, Kashyap R, Aston CE. Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19. Crit Care Med. 2022 10 01; 50(10):e744-e758.

View in: PubMed
Cohen JB, Marcum ZA, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Scharfstein D, Williamson J, Pajewski NM, Bress AP. Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Netw Open. 2022 07 01; 5(7):e2220680.

View in: PubMed
Zhang YQ, Liu XG, Ding Q, Berguson M, Morris RJ, Liu H, Goldhammer JE. Perioperative Renin-Angiotensin System Inhibitors Improve Major Outcomes of Heart Failure Patients Undergoing Cardiac Surgery: A Propensity-Adjusted Cohort Study. Ann Surg. 2023 04 01; 277(4):e948-e954.

View in: PubMed
Keith SW, Maio V, Arafat HA, Alcusky M, Karagiannis T, Rabinowitz C, Lavu H, Louis DZ. Angiotensin blockade therapy and survival in pancreatic cancer: a population study. BMC Cancer. 2022 Feb 07; 22(1):150.

View in: PubMed
Sasongko TH, Nagalla S. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Cochrane Database Syst Rev. 2021 12 21; 12:CD009191.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement